During the past decade, Japan Community Health care Organization Kyushu Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Japan Community Health care Organization Kyushu Hospital" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Bayer" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Japan Community Health care Organization Kyushu Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Japan Community Health care Organization Kyushu Hospital" are "Heart Failure" (3 trials), "Ulcerative Colitis" (2 trials), "Anemia" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials) and "Extensive Disease Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Japan Community Health care Organization Kyushu Hospital" in a lesser frequency.

Most popular intervention types in "Japan Community Health care Organization Kyushu Hospital" are "Drug" (13 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (3 trials), "Etrasimod" (2 trials), "ASA 100 mg" (1 trials) and "Bemarituzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Japan Community Health care Organization Kyushu Hospital" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Japan Community Health care Organization Kyushu Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Japan Community Health care Organization Kyushu Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Japan Community Health care Organization Kyushu Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".